Hot and cold technologies for tissue ablation in urology

Abstract

Increasingly, technology plays an important role in urology, and with this greater use comes the expected increase in regulation. Authors from the UK present a review of the physical properties of ablative technologies, evaluating efficacy and safety, and summarising guidance issued by the National Institute of Health and Clinical Excellence (NICE) where available. There are also reviews from the UK on haematuria, and on the pathology of bladder cancer from an international group of European authors.

The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review

“…Lastly, these effects are uniquely confined within their respective pseudocapsules and prostate zones. The water vapor however cannot penetrate the boundaries between different zones of the prostate, and therefore stays within the zone it targets (Figure 3) [32,33].…”

Technological Improvement Rates and Evolution of Energy-Based Therapeutics

“…The main path analysis of the microwave/RF therapeutic domain ( Figure 8 ) has a single cluster and is used for ablation of tissue for the treatment of cancer (liver, kidney, prostate, lung, and bone metastasis) ( 84 , 85 ), cardiovascular diseases (e.g., arrhythmias) ( 57 , 86 ), gynecological [e.g., endometrial ablation to destroy the uterine lining ( 87 ), urological ( 88 ), and orthopedic disorders. Among these treatments, tumor ablation has the largest share ( 84 ).…”